BPC-157 + TB-500 Blend 2mg ea/ 4MG

Research shows that both peptides, TB-500 and BPC-157, aid in wound healing and speed up recovery from injury, and may show synergistic effects when combined. BPC-157 (Body protection compound 157) is a synthetic derivative of a protein naturally found in human gastric juice. TB-500 is a synthetic derivative of thymosin beta 4, an endogenous peptide present in the thymus gland. On our website, TB-500 and BPC-157 blend for sale is exclusively available for research and educational purchases.

1 Tissue Injury and Repair

BPC-157 has been shown to promote wound healing in skin, muscle, tendon and ligaments. Recovery from tissue injury or wound healing depends on the migration and proliferation of fibroblasts. Migration of fibroblasts is an important step for the re-establishment of cellular and extracellular matrix. It secretes collagen, which helps in wound closure at the site of injury. The movement of fibroblasts is heavily dependent on protein actin. BPC-157 increases the proliferation of fibroblast, plus it upregulates the gene expression responsible for the production of actin [1]. TB-500 has been shown to promote wound healing by sequestering actin molecules at the site suitable for building filaments that facilitate cell movement [2].

2. Angiogenesis

Both TB-500 and BPC-157 promote angiogenesis (formation of new blood vessels) by upregulating the expression of vascular endothelial growth factor (VEGF) [3,4]. Vascular proliferation plays an important role in improving circulation, reducing cardiovascular risk and supporting recovery from injury. Together, these peptides have the potential to exhibit synergistic effects in accelerating recovery from injury. At Element Sarms, the option to buy BPC-157 and TB-500 blend is restricted to research purposes. Only purchase BPC-157 and TB-500 blend if you are a qualified researcher.

1. Chang, C.-H., et al., The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 2011. 110(3): p. 774-780.
2. Kim, J. and Y. Jung, Potential role of thymosin Beta 4 in liver fibrosis. Int J Mol Sci, 2015. 16(5): p. 10624-35.
3. MJo, J.O., et al., Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner. Biochim Biophys Acta, 2010. 1803(11): p. 1244-51
4. Hsieh, M.-J., et al., Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine, 2017. 95(3): p. 323-333.